Consistently, a robust correlation between low ATGL protein expression in cancerous tissues and poor survival rate was reported in patients with non-small-cell lung cancer (NSCLC), pancreatic adenocarcinoma, and leiomyosarcoma [14]. Here, PNPLA2 is linked to non-small cell lung carcinoma.